These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11115583)

  • 1. The significance of thymidine phosphorylase expression in colorectal cancer.
    Katsumata K; Sumi T; Yamashita S; Takahashi S; Mori M; Baba T; Murohashi T; Nagashima K; Ashizawa T; Yamamoto K; Koyanagi Y; Katoh K
    Oncol Rep; 2001; 8(1):127-30. PubMed ID: 11115583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Doxifluridine for treatment of colorectal cancer].
    Nishimura G; Miwa K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():345-8. PubMed ID: 14574909
    [No Abstract]   [Full Text] [Related]  

  • 3. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.
    Schüller J; Cassidy J; Dumont E; Roos B; Durston S; Banken L; Utoh M; Mori K; Weidekamm E; Reigner B
    Cancer Chemother Pharmacol; 2000; 45(4):291-7. PubMed ID: 10755317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival.
    Saif MW; Hashmi S; Bell D; Diasio RB
    Expert Opin Drug Saf; 2009 Sep; 8(5):507-14. PubMed ID: 19663627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5'DFUR) on breast cancer.
    Hata Y; Takahashi H; Sasaki F; Ogita M; Uchino J; Yoshimoto M; Akasaka Y; Nakanishi Y; Sawada Y
    Breast Cancer; 2000 Jan; 7(1):37-41. PubMed ID: 11029769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5'-deoxy-5-fluorocytidine formation.
    Tabata T; Katoh M; Tokudome S; Hosakawa M; Chiba K; Nakajima M; Yokoi T
    Drug Metab Dispos; 2004 Jul; 32(7):762-7. PubMed ID: 15205393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidine phosphorylase expression and effect of doxifluridine: a phase II study.
    Sadahiro S; Otani Y; Oya K; Ike H; Shimada H; Yamaguchi S; Hiki Y; Fujita H; Mitomi T
    Oncol Rep; 2001; 8(4):753-8. PubMed ID: 11410777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine phosphorylase (TP) activation: convenience through innovation.
    Van Cutsem E; Cunningham D; Hoff PM; Maroun J
    Oncologist; 2001; 6 Suppl 4():1-2. PubMed ID: 11585967
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy.
    Sato S; Yajima A; Sasaki H; Mizutani K; Honjo H; Yamamoto K; Ozaki M; Hasegawa K; Kudo T; Yakushiji M; Hatae M; Noda K
    Oncol Rep; 2001; 8(2):239-44. PubMed ID: 11182033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy.
    Nishimura G; Terada I; Kobayashi T; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Kayahara M; Shimizu K; Ohta T; Miwa K
    Oncol Rep; 2002; 9(3):479-82. PubMed ID: 11956613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uridine phosphorylase in breast cancer: a new prognostic factor?
    Yan R; Wan L; Pizzorno G; Cao D
    Front Biosci; 2006 Sep; 11():2759-66. PubMed ID: 16720348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.
    Meropol NJ; Gold PJ; Diasio RB; Andria M; Dhami M; Godfrey T; Kovatich AJ; Lund KA; Mitchell E; Schwarting R
    J Clin Oncol; 2006 Sep; 24(25):4069-77. PubMed ID: 16943524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin.
    Petrioli R; Bargagli G; Lazzi S; Pascucci A; Francini E; Bellan C; Conca R; Martellucci I; Fiaschi AI; Lorenzi B; Francini G;
    Anticancer Drugs; 2010 Mar; 21(3):313-9. PubMed ID: 20016369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacogenetics of capecitabine and its metabolites following replicate administration of two 500 mg tablet formulations.
    Queckenberg C; Erlinghagen V; Baken BC; Van Os SH; Wargenau M; Kubeš V; Peroutka R; Novotný V; Fuhr U
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):1081-91. PubMed ID: 26242222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of thymidine phosphorylase staining and the Ki-67 labeling index to clinicopathologic factors and hepatic metastasis in patients with colorectal cancer.
    Kitabatake T; Kojima K; Fukasawa M; Beppu T; Futagawa S
    Surg Today; 2002; 32(4):322-8. PubMed ID: 12027197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro evaluation of transportability and toxicity of capecitabine and its metabolites in cells derived from normal human kidney and renal cancers.
    Damaraju VL; Mowles D; Wilson M; Kuzma M; Cass CE; Sawyer MB
    Biochem Cell Biol; 2013 Dec; 91(6):419-27. PubMed ID: 24219283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study.
    Koopman M; Venderbosch S; van Tinteren H; Ligtenberg MJ; Nagtegaal I; Van Krieken JH; Punt CJ
    Eur J Cancer; 2009 Jul; 45(11):1999-2006. PubMed ID: 19457654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of peroral doxifluridine plus hepatic arterial infusion for synchronous liver metastasis of colorectal cancer--correlation with the expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in primary colorectal cancer lesions].
    Ishida H; Fujioka M; Ohsawa T; Takeuchi I; Nakada H; Ishizuka N; Yokoyama M; Inokuma S; Yamada H; Odaka A; Hoshino T; Murata N; Hashimoto D; Matsumoto Y; Miura T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1624-7. PubMed ID: 11707995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of numeric aberrations of genes for thymidylate synthase, thymidine phosphorylase and dihydrofolate reductase in colorectal cancer.
    Jensen SA; Vainer B; Witton CJ; Jørgensen JT; Sørensen JB
    Acta Oncol; 2008; 47(6):1054-61. PubMed ID: 18607850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.